COVID-19 is notified as a public health crisis of international concern by the World Health Organization.
Several clinical, genetic and epidemiological features of COVID-19 resemble SARS-CoV. There is need to search
herbal antiviral agents having efficacy against a broad spectrum of viruses especially against SARS-CoV. Glycyrrhiza
Glabra (Yasthimadhu) has found same documented efficacy.
The aim of this review is to systematically assess the evidence from various experimental and other studies for the
efficacy of GG in the treatment of SARS-CoV. Also, to addresses the modern evidences for this activity and
establishes the relationship amongst classical and modern aspects.
The search for suitable papers in Pub-Med was carried out. Ayurvedic classics records on the in ancient
Ayurveda books were searched. In Charaka, 194 references were found out of which 70 relevant were taken for
analysis. In Sushrut Samhita, total 174 references were found. Among which, 49 were taken for analysis. Seven
Nighantus were searched out. Documented studies show the GG has efficacy in treatment of SARS-CoV. Also has
potential for the therapy and prophylaxis against SARS-CoV -2.
KEYWORDS: Glycyrrhiza Glabra, Yasthimadhu, SARS-CoV